Patient-centered approaches to research design are particularly important for diseases with complex treatment decision-making, such as recurrent, high-grade non-muscle-invasive bladder cancer (NMIBC).
Both lncRNAs and glycolysis are considered to be key influencing factors in the progression of bladder cancer (BCa). Studies have shown that glycolysis-related lncRNAs are an important factor affecting the overall survival and prognosis of patients with bladder cancer.
(UroToday.com) The AUA annual meeting’s evolving landscape of advanced prostate cancer treatment session included a talk by Dr. Deborah Kaye discussing the role of immunotherapy and PARP inhibitors. Dr. Kaye started by highlighting that there are currently numerous options for systemic treatment of mCRPC. As follows is a summary of the mCRPC first and second line […]
(UroToday.com) The Society of Urologic Oncology held an associated session at the American Urologic Association Virtual Annual Meeting entitled “The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion”. Dr. David Jarrard provided an overview of the use of agents targeting the androgen axis.
(UroToday.com) The Society of Urologic Oncology held an associated session at the American Urologic Association Virtual Annual Meeting entitled “The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion.” Dr. Kelly Stratton followed Dr. Boorjian’s initial talk with a discussion of the role of imaging in advanced prostate cancer.
(UroToday.com) The Society of Urologic Oncology held an associated session at the American Urologic Association Virtual Annual Meeting entitled “The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion.” Building on presentations from Dr. Stephen Boorjian and Dr. Kelly Stratton regarding biochemical recurrence and imaging, respectively, Dr. Michael Cookson discussed the management of […]
(UroToday.com) The American Urologic Association (AUA) annual meeting’s evolving landscape of advanced prostate cancer treatment session included a talk by Dr. Stephen Boorjian discussing bone health and radionuclide therapy. Dr. Boorjian notes that there are several clinically relevant aspects of bone health in CRPC including (i) the issue of bone loss, given that the median age […]
(UroToday.com) The American Urologic Association (AUA) annual meeting’s evolving landscape of advanced prostate cancer treatment session included a talk by Dr. Leonard Gomella discussing genetic testing in advanced prostate cancer. Dr. Gomella notes that there have been rapid advances in prostate cancer genetic testing, reflected in changes made to the NCCN guidelines from 2016-2020. Before 2016, […]
(UroToday.com) The Society of Urologic Oncology held an associated session at the American Urologic Association Virtual Annual Meeting entitled “The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion.” Dr. Stephen Boorjian began this session with a talk focusing on the identification of patients with high-risk prostate cancer and the initial management of […]
Ashish Kamat: Hello, and welcome to UroToday’s Bladder Cancer Center of Excellence. I’m Ashish Kamat, Professor of Urologic Oncology and Cancer Research at MD Anderson Cancer Center in Houston. And it’s a great pleasure to welcome today a friend and a colleague from right down the street, so to speak, from Galveston, Dr. Stephen Williams, […]
